SETTLEMENT AGREEMENT AND MUTUAL GENERAL RELEASESettlement Agreement • June 11th, 2003 • Ciphergen Biosystems Inc • Services-commercial physical & biological research • California
this technology transfer agreement (the “Agreement”) is made and entered into on this 7th day of April, 1997 (the “Effective Date”) and is retroactive to September 16, 1996 (the “Retroactive Date”), by and between molecular analytical systems, inc. (“MAS”), a Texas corporation with an address c/o Wagner, Kirkman & Blaine, 1792 Tribute Road, Suite 450, Sacramento, CA 95815, and illumesys pacific, inc. (“IllumeSys”), a California corporation with an address c/o Wagner, Kirkman & Blaine, 1792 Tribute Road, Suite 450, Sacramento, CA 95815.
ASSIGNMENT AGREEMENTAssignment Agreement • June 11th, 2003 • Ciphergen Biosystems Inc • Services-commercial physical & biological research • California
This Assignment Agreement (“Assignment Agreement”) is made and entered into on May 28, 2003 (the “Execution Date”) and is effective as of February 21, 2003 (the “Effective Date”) by and between Ciphergen Biosystems, Inc. (“CBI”), IllumeSys Pacific, Inc. (“IllumeSys”), and Ciphergen Technologies, Inc. (“CTI”), (collectively referred to herein as “Ciphergen”) on the one hand, and Molecular Analytical Systems, Inc. (“MAS”), LumiCyte, Inc. (“LumiCyte”), and T. William Hutchens (“Hutchens”), on the other. Ciphergen, MAS, LumiCyte, and Hutchens are sometimes referred to individually as a “Party” and collectively as the “Parties.”
CIPHERGEN BIOSYSTEMS, INC. SHARE PURCHASE AGREEMENT Dated May 28, 2003Share Purchase Agreement • June 11th, 2003 • Ciphergen Biosystems Inc • Services-commercial physical & biological research • California
This SHARE PURCHASE AGREEMENT (this “Agreement”) is made and entered into on May 28, 2003 (the “Execution Date”) and effective as of February 21, 2003 (the “Effective Date”), by and among Ciphergen Biosystems, Inc., a Delaware corporation (the “Company”) and LumiCyte, Inc., a California corporation (the “Purchaser”).
EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • June 11th, 2003 • Ciphergen Biosystems Inc • Services-commercial physical & biological research • California
This Exclusive License Agreement (“Exclusive License Agreement”) is made and entered into on May 28, 2003 (the “Execution Date”) and effective as of February 21, 2003 (the “Effective Date”) by and between Molecular Analytical Systems, Inc. (“MAS”) and Ciphergen Biosystems, Inc. (“CBI”). MAS and CBI may each be referred to herein individually as a “Party” or, collectively, as “Parties.”
